Breaking News, Promotions & Moves

Rentschler Biopharma Appoints Christiane Bardroff as COO

Bardroff will head clinical and commercial manufacturing, engineering and technology operations, as well as production automation.

Author Image

By: Charlie Sternberg

Associate Editor

Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has appointed Christiane Bardroff as chief operating officer (COO), effective December 1, 2022.   With this expansion of its Executive Board, Rentschler Biopharma is strengthening its focus on its core operations to ensure it delivers the highest quality products and services to its clients and partners. Bardroff will head clinical and commercial manufacturing, engineering and t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters